CSIMarket
 


Bruker Corporation  (BRKR)
Other Ticker:  
 
 

BRKR's Operating Income Growth by Quarter and Year

Bruker's Operating Income results by quarter and year




BRKR Operating Income (in millions $) FY 2023 FY 2022 FY 2021 FY 2020
IV Quarter December - 131.00 125.40 81.20
III Quarter September 124.50 131.30 113.20 37.90
II Quarter June 86.20 73.90 85.60 16.40
I Quarter March 122.70 96.50 89.10 117.70
FY   333.40 432.70 413.30 253.20



BRKR Operating Income third quarter 2023 Y/Y Growth Comment
Bruker Corporation reported decrease in Operating Income in the third quarter 2023 by -5.18% to $ 124.50 millions, from the same quarter in 2022.
The decrease in the third quarter 2023 Bruker Corporation's Operating Income compares unfavorably to the Company's average Operating Income rise of 35.67%.

Looking into third quarter 2023 results within Laboratory Analytical Instruments industry 3 other companies have achieved higher Operating Income growth. While Bruker Corporation' s Operating Income decline of -5.18% ranks overall at the positon no. 1232 in the third quarter 2023.

Explain Operating Income growth


BRKR Operating Income ( Y/Y Growth %) 2023
2022 2021 2020
IV Quarter December - 4.47 % 54.43 % -7.52 %
III Quarter September -5.18 % 15.99 % 198.68 % -29.16 %
II Quarter June 16.64 % -13.67 % 421.95 % -60.86 %
I Quarter March 27.15 % 8.31 % -24.3 % 11.78 %
FY   - 4.69 % 63.23 % -12.24 %

Financial Statements
Bruker's third quarter 2023 Operating Income $ 124.50 millions BRKR's Income Statement
Bruker's third quarter 2022 Operating Income $ 131.30 millions Quarterly BRKR's Income Statement
New: More BRKR's historic Operating Income Growth >>


BRKR Operating Income (Quarter on Quarter Growth %)

2023
2022 2021 2020
IV Quarter December - -0.23 % 10.78 % 114.25 %
III Quarter September 44.43 % 77.67 % 32.24 % 131.1 %
II Quarter June -29.75 % -23.42 % -3.93 % -86.07 %
I Quarter March -6.34 % -23.05 % 9.73 % 34.05 %
FY (Year on Year)   - 4.69 % 63.23 % -12.24 %




Operating Income third quarter 2023 Y/Y Growth Company Ranking
Within: No.
Laboratory Analytical Instruments Industry #4
Healthcare Sector #90
Overall #1232

Operating Income Y/Y Growth Statistics
High Average Low
475.51 % 35.67 % -84.44 %
(Sep 30 2015)   (Sep 30 2014)
Operating Income third quarter 2023 Y/Y Growth Company Ranking
Within: No.
Laboratory Analytical Instruments Industry #4
Healthcare Sector #90
Overall #1232
Operating Income Y/Y Growth Statistics
High Average Low
475.51 % 35.67 % -84.44 %
(Sep 30 2015)   (Sep 30 2014)

Operating Income by Quarter for the Fiscal Years 2020, 2021, 2022, 2023

Bruker's Q/Q Operating Income Growth


Operating Income Q/Q Growth Statistics
High Average Low
808.16 % 41.07 % -86.16 %
(Dec 31 2014)  


BRKR's III. Quarter Q/Q Operating Income Comment
Bruker Corporation achieved in the III. Quarter 2023 above company average sequential Operating Income jump of 44.43%, to $ 124.50 millions, from $86.20 millions in the second quarter.

Within Laboratory Analytical Instruments industry only one company achieved higher sequential Operating Income growth. While Bruker's Operating Income growth quarter on quarter, overall rank is 373.


Operating Income Q/Q Growth Company Ranking
Within: No.
Laboratory Analytical Instruments Industry #2
Healthcare Sector #26
Overall #373
Operating Income Q/Q Growth Company Ranking
Within: No.
Laboratory Analytical Instruments Industry #2
Healthcare Sector #26
Overall #373
Operating Income Q/Q Growth Statistics
High Average Low
808.16 % 41.07 % -86.16 %
(Dec 31 2014)  


BRKR's III. Quarter Q/Q Operating Income Comment
Bruker Corporation achieved in the III. Quarter 2023 above company average sequential Operating Income jump of 44.43%, to $ 124.50 millions, from $86.20 millions in the second quarter.

Within Laboratory Analytical Instruments industry only one company achieved higher sequential Operating Income growth. While Bruker's Operating Income growth quarter on quarter, overall rank is 373.


Bruker's 12 Months Operating Income Growth Year on Year


Operating Income TTM Growth

12 Months Ending
(Sep 30 2023)
12 Months Ending
(Jun 30 2023)
12 Months Ending
(Mar 31 2023)
12 Months Ending
(Dec 31 2022)
12 Months Ending
(Sep 30 2022)
Cumulative Operating Income 12 Months Ending $ 464.40 $ 471.20 $ 458.90 $ 432.70 $ 427.10
Y / Y Operating Income Growth (TTM) 8.73 % 15.21 % 9.08 % 4.69 % 15.71 %
Year on Year Operating Income Growth Overall Ranking # 716 # 469 # 271 # 280 # 871
Seqeuential Operating Income Change (TTM) -1.44 % 2.68 % 6.06 % 1.31 % 4.43 %
Seq. Operating Income Growth (TTM) Overall Ranking # 937 # 1170 # 1083 # 769 # 912




Cumulative Operating Income growth Comment
With the quarterly Operating Income reported in the Sep 30 2023 period, Bruker's cumulative twelve months Operating Income were $ 464 millions, company would post below average annual Operating Income growth of 4.43% year on year, if the fiscal year would end at Sep 30 2023.
A slow-down in the Bruker's Operating Income growth from the 86.2% growth in Jun 30 2023. Comparing the results with it's peers in Laboratory Analytical Instruments industry, Bruker's trailing twelve months Operating Income growth, were the second highest.

In the Healthcare sector 39 other companies have achieved higher trailing twelve month Operating Income growth. While Operating Income growth total ranking has deteriorated compare to previous quarter from 469 to 716.

Operating Income TTM Q/Q Growth Statistics
High Average Low
87.31 %
14.86 %
-36.14 %
 

Operating Income TTM Y/Y Growth Company Ranking
Within: No.
Laboratory Analytical Instruments Industry # 2
Healthcare Sector # 40
Overall # 716

Operating Income TTM Y/Y Growth Statistics
High Average Low
87.31 %
14.86 %
-36.14 %
 


Operating Income TTM Q/Q Growth Company Ranking
Within: No.
Industry # 2
Sector # 52
S&P 500 # 937
Cumulative Operating Income growth Comment
With the quarterly Operating Income reported in the Sep 30 2023 period, Bruker's cumulative twelve months Operating Income were $ 464 millions, company would post below average annual Operating Income growth of -36.14% year on year, if the fiscal year would end at Sep 30 2023.
A slow-down in the Bruker's Operating Income growth from the 86.2% growth in Jun 30 2023. Comparing the results with it's peers in Laboratory Analytical Instruments industry, Bruker's trailing twelve months Operating Income growth, were the second highest.

In the Healthcare sector 39 other companies have achieved higher trailing twelve month Operating Income growth. While Operating Income growth total ranking has deteriorated compare to previous quarter from 469 to 716.

Operating Income TTM Q/Q Growth Statistics
High Average Low
87.31 %
14.86 %
-36.14 %
 


Operating Income TTM Y/Y Growth Company Ranking
Within: No.
Laboratory Analytical Instruments Industry # 2
Healthcare Sector # 40
Overall # 716

Operating Income TTM Y/Y Growth Statistics
High Average Low
87.31 %
14.86 %
-36.14 %
 


Operating Income TTM Q/Q Growth Company Ranking
Within: No.
Industry # 2
Sector # 52
S&P 500 # 937




Other Operating Income Growth
Laboratory Analytical Instruments Industry Operating Income Growth Trends and Statistics
Healthcare Sector Operating Income Growth Statistics
Operating Income Growth Trends for overall market
BRKR's Operating Income Growth Ratio versus Laboratory Analytical Instruments Industry, Healthcare Sector and total Market
Highest Ranking Operating Income Growth
Lowest Ranking Operating Income Growth
Operating Income Growth for BRKR's Competitors
Operating Income Growth for Bruker's Suppliers
Operating Income Growth for BRKR's Customers

You may also want to know
BRKR's Annual Growth Rates BRKR's Profitability Ratios BRKR's Asset Turnover Ratio BRKR's Dividend Growth
BRKR's Roe BRKR's Valuation Ratios BRKR's Financial Strength Ratios BRKR's Dividend Payout Ratio
BRKR's Roa BRKR's Inventory Turnover Ratio BRKR's Growth Rates BRKR's Dividend Comparisons



Companies with similar Operating Income jump for the quarter ending Sep 30 2023 within Healthcare SectorY/Y Change %Operating Income for the quarter ending Sep 30 2023
Bio techne Corp-0.81%$ -0.808 millions
The Pennant Group Inc -1.16%$ -1.162 millions
Bio rad Laboratories Inc -1.99%$ -1.990 millions
Corcept Therapeutics Inc-2.37%$ -2.371 millions
Mettler toledo International Inc -3.07%$ -3.068 millions
Tenet Healthcare Corp-4.70%$ -4.698 millions
West Pharmaceutical Services Inc -4.78%$ -4.780 millions
Bruker Corporation-5.18%$ -5.179 millions
Henry Schein Inc-5.21%$ -5.213 millions
Hologic Inc-5.96%$ -5.962 millions
Sonida Senior Living Inc -6.27%$ -6.269 millions
Abbott Laboratories-6.95%$ -6.949 millions
Gilead Sciences Inc -7.54%$ -7.543 millions
Vertex Pharmaceuticals Inc-7.86%$ -7.864 millions
Bristol myers Squibb Company-9.18%$ -9.183 millions
Regeneron Pharmaceuticals Inc -9.21%$ -9.210 millions
National Research Corporation-10.39%$ -10.388 millions
Quest Diagnostics Inc-12.76%$ -12.755 millions
Bausch and Lomb Corp-13.04%$ -13.043 millions
Carlisle Companies Incorporated-13.87%$ -13.871 millions
Pediatrix Medical Group Inc -15.01%$ -15.015 millions
Community Health Systems Inc -15.20%$ -15.196 millions
Teva Pharmaceutical Industries Limited-15.27%$ -15.274 millions
Zynex inc -16.36%$ -16.362 millions
Entera Bio Ltd -16.72%$ -16.719 millions
Pacira Biosciences inc -16.76%$ -16.760 millions
Viatris Inc -19.35%$ -19.354 millions
Royalty Pharma Plc-21.21%$ -21.210 millions
Luna Innovations Inc-22.06%$ -22.057 millions
Avantor Inc -23.79%$ -23.785 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com